Retatrutide shows promise in Phase 3 obesity trials, enhancing weight loss and A1C control | Retatrutide News

Retatrutide has shown significant improvements in weight and A1C levels in two Phase 3 obesity trials. This positions the drug as a promising addition t...
Clinical Trials · October 25, 2026